A LINC00472 transcript (2933 bp, NR_026807.1) was assembled and inserted in a lentiviral vector, pCDH-EF1-MCS-pA-PGK-copGFP-T2A-Puro (pCDH), as previously described (13 (link)). The sequence of the insert has been confirmed by sequencing. MB231 and Hs578T cells were transfected with the LINC00472 plasmid or an empty plasmid (pCDH vector only) using the Lipofectamine 3000 reagent (Thermo Fisher Scientific) following the manufacturer's protocol. Cells with stable expression of LINC00472 were selected through puromycin screening (Thermo Fisher Scientific). To maintain stably transfected cells, puromycin was added into culture medium, and the puromycin-containing culture medium was replaced every 3 days. A single cell clone was also generated from the stable cell pool through the limiting dilution cloning. Plasmids (pCMV-ESR1) with and without the full-length of human ESR1 (NM_000125, #RC213277) and (pCMV-vector, #PS100001), respectively, were purchased from Origene Technologies, and the plasmids were transfected into the 293T cells and breast cancer cell lines using the Lipofectamine 3000 reagent (Themo Fisher Scientific).